EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineering of High‐Yield Recombinant Adeno‐Associated Virus Producer Plasmids

Marco T Radukic, Dinh To Le, Robert Freudenberg, Anne Hammann, Omar Hamdan, Claire Rothschild-Gronau, Raimund Hoffrogge, Susanne K Golm, Rebecca C Feiner, Kathrin E Teschner, Kristian M Müller

Biotechnology Journal · 2026-01 · 21 (1)

DOI: 10.1002/biot.70179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 14.01.2026. Verfasst von Marco T Radukic und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Biotechnology, Faculty of Technology, Bielefeld University, Bielefeld, Germany. Hauptthemen laut MEDLINE: Plasmids, Dependovirus, Genetic Engineering. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno‐associated virus (rAAV) production lags demand with respect to quality and quantity. We report insights from producer plasmid engineering aimed at increasing yield and homogeneity of rAAV vectors obtained by HEK‐293 triple transfection. Miniaturized production and same‐day quantification streamlined the investigation. We demonstrate that modifications of the AAV2 Rep gene cluster reduces titers of currently circulating packaging plasmids. Revertants to wild type yielded 116‐fold higher titers of about 10 6 particles per cell and reduced mispackaging. Modifications of predicted Rep post‐translational modification sites decreased the empty capsid titer burden. A 7 kbp minimal helper plasmid lacking L4 22k maintained production capability upon optimized Rep expression for AAV2 but not for AAV6 and AAV9. Knockout of the egress protein MAAP increased rAAV yield from the cell pellet for convenient lysate processing. Together, these findings highlight the importance and potential tradeoffs of designing producer plasmids to obtain high titer systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlasmidsDependovirusGenetic EngineeringHumansHEK293 CellsGenetic VectorsTransfectionViral Proteins

Stichwörter der Autor:innen

Ad5 helper plasmidadeno‐associated virus (AAV)membrane‐associated accessory protein (MAAP)plasmid engineeringreplicase (Rep)

Substanzen

Viral Proteins

Autor:innen und Institutionen

  • Cellular and Molecular Biotechnology, Faculty of Technology, Bielefeld University, Bielefeld, Germany.
  • Center for Biotechnology (CeBiTec), Bielefeld University, Bielefeld, Germany.

Zitieren

APA

Radukic, M. T., Le, D. T., Freudenberg, R., Hammann, A., Hamdan, O., Rothschild-Gronau, C., Hoffrogge, R., Golm, S. K., Feiner, R. C., Teschner, K. E., & Müller, K. M. (2026). Engineering of High‐Yield Recombinant Adeno‐Associated Virus Producer Plasmids. Biotechnology Journal, 21(1). https://doi.org/10.1002/biot.70179

Vancouver

Radukic MT, Le DT, Freudenberg R, Hammann A, Hamdan O, Rothschild-Gronau C, et al. Engineering of High‐Yield Recombinant Adeno‐Associated Virus Producer Plasmids. Biotechnology Journal. 2026;21(1). doi:10.1002/biot.70179

BibTeX
@article{Radukic2026,
  author = {Radukic, Marco T and Le, Dinh To and Freudenberg, Robert and Hammann, Anne and Hamdan, Omar and Rothschild-Gronau, Claire and Hoffrogge, Raimund and Golm, Susanne K and Feiner, Rebecca C and Teschner, Kathrin E and Müller, Kristian M},
  title = {Engineering of High‐Yield Recombinant Adeno‐Associated Virus Producer Plasmids},
  journal = {Biotechnology Journal},
  year = {2026},
  volume = {21},
  number = {1},
  doi = {10.1002/biot.70179}
}
Kostenlos starten →